Industry
Biotechnology
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Loading...
Open
27.01
Mkt cap
12B
Volume
1.6M
High
27.03
P/E Ratio
17.68
52-wk high
31.66
Low
26.30
Div yield
0.03
52-wk low
25.20
Portfolio Pulse from Benzinga Newsdesk
October 25, 2024 | 6:27 pm
Portfolio Pulse from Benzinga Insights
October 08, 2024 | 6:45 pm
Portfolio Pulse from Benzinga Insights
September 18, 2024 | 5:35 pm
Portfolio Pulse from Vandana Singh
September 04, 2024 | 1:09 pm
Portfolio Pulse from Benzinga Newsdesk
September 03, 2024 | 9:14 pm
Portfolio Pulse from Avi Kapoor
August 16, 2024 | 1:28 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 11:10 am
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 2:45 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 11:03 am
Portfolio Pulse from Avi Kapoor
June 12, 2024 | 1:15 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.